Prognosis of Differentiated Thyroid Cancer in Relation to Serum Thyrotropin and Thyroglobulin Antibody Status at Time of Diagnosis

DOI Web Site Web Site 1 Citations
  • Donald S.A. McLeod
    Department of Internal Medicine & Aged Care, Royal Brisbane and Women's Hospital, Herston, Australia.
  • David S. Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Paul W. Ladenson
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Kenneth B. Ain
    Department of Internal Medicine, Veterans Affairs Medical Center and University of Kentucky, Lexington, Kentucky.
  • James D. Brierley
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada.
  • Henry G. Fein
    Division of Endocrinology and Metabolism, Sinai Hospital, Baltimore, Maryland.
  • Bryan R. Haugen
    Division of Endocrinology, Metabolism, and Diabetes, University of Colorado School of Medicine, Aurora, Colorado.
  • Jacqueline Jonklaas
    Division of Endocrinology, Department of Medicine, Georgetown University Medical Center, Washington, District of Columbia.
  • James Magner
    Genzyme Corporation, Cambridge, Massachusetts.
  • Douglas S. Ross
    Thyroid Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Monica C. Skarulis
    Diabetes, Endocrinology, Obesity Branch, National Institutes of Health, Bethesda, Maryland.
  • David L. Steward
    Department of Head and Neck Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio.
  • Harry R. Maxon
    Department of Nuclear Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio.
  • Steven I. Sherman for the National Thyroid Ca
    Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, Houston, Texas.

Journal

  • Thyroid

    Thyroid 24 (1), 35-42, 2014-01

    Mary Ann Liebert Inc

Citations (1)*help

See more

Keywords

Report a problem

Back to top